Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

• Status: Completed
• Trial end date: 2012-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Have inadequate eyelashes

• Never used prescription eyelash growth products

Exclusion Criteria:

• No visible eyelashes

• Permanent eyeliner or eyelash implants

• Semi-permanent eyelash tint, dye, or extensions within 3 months

• Over-the-counter eyelash growth products within 6 months

• Any disease, infection or abnormality of the eye or area around the eye

• Eye surgery within 3 months, or the anticipated need for eye surgery during the study

• Unable or unwilling to keep contact lenses out during drug application and for 30 minutes after application